Laura van Dussen

1.3k total citations
33 papers, 905 citations indexed

About

Laura van Dussen is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Laura van Dussen has authored 33 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 14 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Laura van Dussen's work include Lysosomal Storage Disorders Research (26 papers), Trypanosoma species research and implications (11 papers) and Cellular transport and secretion (9 papers). Laura van Dussen is often cited by papers focused on Lysosomal Storage Disorders Research (26 papers), Trypanosoma species research and implications (11 papers) and Cellular transport and secretion (9 papers). Laura van Dussen collaborates with scholars based in Netherlands, United States and Israel. Laura van Dussen's co-authors include Carla E. M. Hollak, Johannes M. F. G. Aerts, Marieke Biegstraaten, J.E.M. Groener, Mario Maas, Rolf G. Boot, Marcel G. W. Dijkgraaf, Maarten Arends, Erik M. Akkerman and Anna Tylki‐Szymańska and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Laura van Dussen

30 papers receiving 877 citations

Peers

Laura van Dussen
Nora Watman Argentina
R J Desnick United States
J. B. C. de Klerk Netherlands
R. Gatti Italy
W. J. Kleijer Netherlands
Celeste Decker United States
Nora Watman Argentina
Laura van Dussen
Citations per year, relative to Laura van Dussen Laura van Dussen (= 1×) peers Nora Watman

Countries citing papers authored by Laura van Dussen

Since Specialization
Citations

This map shows the geographic impact of Laura van Dussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura van Dussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura van Dussen more than expected).

Fields of papers citing papers by Laura van Dussen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura van Dussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura van Dussen. The network helps show where Laura van Dussen may publish in the future.

Co-authorship network of co-authors of Laura van Dussen

This figure shows the co-authorship network connecting the top 25 collaborators of Laura van Dussen. A scholar is included among the top collaborators of Laura van Dussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura van Dussen. Laura van Dussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dussen, Laura van, Marion M. Brands, Bregje Jaeger, et al.. (2025). Effectiveness of Pyridoxal‐5′‐Phosphate in PNPO Deficiency: A Systematic Review. Journal of Inherited Metabolic Disease. 48(5). e70074–e70074.
2.
Tchan, Michel, Anna Lehman, Laura van Dussen, et al.. (2025). The Frequencies of Different Inborn Errors of Metabolism in Adult Metabolic Centres: 10 Years Later, Another Report From the SSIEM Adult Metabolic Physicians Group. Journal of Inherited Metabolic Disease. 48(2). e70005–e70005. 2 indexed citations
3.
Dussen, Laura van, Marion M. Brands, Frédéric M. Vaz, et al.. (2024). Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria. Journal of Inherited Metabolic Disease. 48(1). e12789–e12789. 2 indexed citations
4.
Dussen, Laura van, Johannes M. F. G. Aerts, Mario Maas, et al.. (2024). Acid sphingomyelinase deficiency and Gaucher disease in adults: Similarities and differences in two macrophage storage disorders. JIMD Reports. 65(5). 330–340. 1 indexed citations
5.
Dussen, Laura van, et al.. (2024). Establishing Treatment Effectiveness in Fabry Disease: Observation-Based Recommendations for Improvement. International Journal of Molecular Sciences. 25(17). 9752–9752. 4 indexed citations
6.
Dussen, Laura van, E. Marleen Kemper, Frédéric M. Vaz, et al.. (2024). The clinical and biochemical effectiveness and safety of cholic acid treatment for bile acid synthesis defects: a systematic review. Orphanet Journal of Rare Diseases. 19(1). 466–466.
7.
Dussen, Laura van, et al.. (2023). Progressive Changes in Cerebral Apparent Diffusion Values in Fabry Disease: A 5-Year Follow-up MRI Study. American Journal of Neuroradiology. 44(10). 1157–1164. 2 indexed citations
8.
Ree, Martijn H. van der, Laura van Dussen, Bart Jacobs, et al.. (2022). Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review. EP Europace. 24(11). 1809–1823. 15 indexed citations
9.
Dussen, Laura van, André B. P. Kuilenburg, Marcel G. W. Dijkgraaf, et al.. (2020). Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease. International Journal of Molecular Sciences. 21(16). 5784–5784. 51 indexed citations
10.
Dussen, Laura van, et al.. (2017). What do people want to know about NIPT? Content analysis of questions emailed to national NIPT information websites. Prenatal Diagnosis. 37(4). 412–415. 7 indexed citations
11.
Boer, Geertje M. de, Laura van Dussen, Leon M. van den Toorn, et al.. (2016). Lung Transplantation in Gaucher Disease. CHEST Journal. 149(1). e1–e5. 14 indexed citations
12.
Dussen, Laura van, et al.. (2014). Heterogeneous pattern of bone disease in adult type 1 Gaucher disease: Clinical and pathological correlates. Blood Cells Molecules and Diseases. 53(3). 118–123. 8 indexed citations
13.
Dussen, Laura van, Marieke Biegstraaten, Carla E. M. Hollak, & Marcel G. W. Dijkgraaf. (2014). Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease. Orphanet Journal of Rare Diseases. 9(1). 51–51. 41 indexed citations
14.
Bohte, Anneloes E., Laura van Dussen, Erik M. Akkerman, et al.. (2013). Liver Fibrosis in Type I Gaucher Disease: Magnetic Resonance Imaging, Transient Elastography and Parameters of Iron Storage. PLoS ONE. 8(3). e57507–e57507. 48 indexed citations
15.
Dussen, Laura van, Ari Zimran, Erik M. Akkerman, et al.. (2012). Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Molecules and Diseases. 50(3). 206–211. 31 indexed citations
16.
Dussen, Laura van, Timothy M. Cox, Erik Hendriks, et al.. (2012). Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes. Haematologica. 97(12). 1850–1854. 15 indexed citations
17.
Dussen, Laura van, Carla E. M. Hollak, Ari Zimran, et al.. (2012). Long Term Bone Marrow Responses, as Measured by Quantitative Chemical Shift Imaging (QCSI) MRI, Following Treatment With Taliglucerase Alfa in Patients with Type 1 Gaucher Disease. Molecular Genetics and Metabolism. 105(2). S62–S63. 2 indexed citations
18.
Dussen, Laura van, Paul Lips, Vincent Everts, et al.. (2011). Markers of Bone Turnover in Gaucher Disease: Modeling the Evolution of Bone Disease. The Journal of Clinical Endocrinology & Metabolism. 96(7). 2194–2205. 45 indexed citations
19.
Hollak, Carla E. M., Maaike de Fost, Laura van Dussen, Stephan vom Dahl, & Johannes M. F. G. Aerts. (2009). Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose – response relationships. Expert Opinion on Pharmacotherapy. 10(16). 2641–2652. 18 indexed citations
20.
Boot, Rolf G., Mariëlle J. van Breemen, Richard R. Sprenger, et al.. (2009). Gaucher disease: a model disorder for biomarker discovery. Expert Review of Proteomics. 6(4). 411–419. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026